YOLFTbeta
60

Jianerkang Medical Co.,Ltd.

603205 · SHG · Healthcare / Medical Instruments & Supplies

20.88CNY-0.34 (-1.60%)

Price History

Full chart

Market Stats

Previous Close21.22
Open21.21
Day Range20.80 – 21.32
52-Week Range19.57 – 30.68
Volume498.40K
Market Cap3.30B
P/E (TTM)26.77
Forward P/E0.00
EPS0.79
Dividend Yield1.18%
50-Day Avg21.72
200-Day Avg23.80

About

Jianerkang Medical Co.,Ltd. engages in the production, and sales of disposable medical devices, medical dressings, and disinfection and hygiene products in China and internationally. It offers surgical supplies; cleansing and disinfetants, such as carrier disinfectants, wet and dry wipes; wound care products, such as wound and medical dressings, bandaging and fixation, and procedure pack products; infection control and protection products; polymer products, such as drainage, anesthesia, gel, and irrigation products; and non-woven products. The company was founded in 1993 and is based in Changzhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Guoping Chen
  • Employees1.69K
  • HeadquartersNo. 1, Jianerkang Road, Changzhou, China, 213251, China
  • Websitehttps://www.chinajek.com/

Leadership

  • Mr. Guoping ChenChairman & GM · b. 1962
  • Mr. Xiao Le GongChief Financial Officer · b. 1980
  • Mr. Hou Quan GanDeputy GM & Director · b. 1975
  • Mr. Luo Jun ChenDeputy GM & Director · b. 1965
  • Mr. Shan YuDeputy Manager of Supply Department & Director · b. 1991
  • Ms. Qin ZhongDeputy Manager of Finance Department & Director · b. 1974
  • Mr. Ping LiuSecretary & Director · b. 1985
  • Mr. Ping WangDeputy General Manager · b. 1964
  • Mr. Shui Ping ChenDeputy General Manager · b. 1956
  • Dong Jin SongAccounting Supervisor

Financials

Income Statement

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Total Revenue1.09B1.03B1.05B1.02B
Growth (%)--5.46%+1.18%-2.04%
Cost of Revenue829.19M797.57M804.55M769.90M
Gross Profit264.05M235.96M241.22M254.48M
Gross Margin24.15%22.83%23.07%24.84%
Operating Expense94.18M85.87M109.67M122.09M
Operating Income169.87M150.09M131.54M132.39M
Operating Margin15.54%14.52%12.58%12.92%
EBITDA221.76M184.88M180.37M175.24M
EBITDA Margin20.28%17.89%17.25%17.11%
Net Income157.34M123.55M120.22M111.44M
Net Income Margin14.39%11.95%11.50%10.88%
R&D35.30M36.59M40.72M40.68M
R&D as % of Total Revenue3.23%3.54%3.89%3.97%
Interest Expense6.63M1.30M5.10K1.16M
Interest Expense % of Total Revenue0.61%0.13%0.00%0.11%

Balance Sheet

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Total Assets1.03B1.11B1.59B1.71B
Total Liabilities245.18M204.22M170.43M216.16M
Total Equity783.29M909.35M1.42B1.49B
Cash178.25M226.24M721.81M764.91M

Cash Flow

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow163.01M157.80M141.10M158.79M
Capital Expenditure66.32M84.18M39.75M69.98M
Free Cash Flow96.70M73.62M101.35M88.81M
Dividends Paid1.66M693.79K-42.12M
FCF to OCF59.32%46.66%71.83%55.93%
Dividend Paid to FCF1.72%0.94%-47.43%

Key Statistics & Ratios

Market Cap3.30B
Enterprise Value2.54B
Trailing P/E26.77
Forward P/E0.00
Price / Sales3.00
Price / Book2.13
EPS0.79
Book Value10.31
Revenue (TTM)1.10B
Gross Profit (TTM)271.03M
EBITDA197.03M
Profit Margin11.23%
Operating Margin18.43%
Return on Equity8.22%
Return on Assets5.50%
Shares Outstanding156.00M
Shares Float0
Dividend Yield1.18%
Dividend Rate0.25
Payout Ratio31.65%